Ear-Zapping gadget could ease opioid withdrawal
NCT ID NCT07079826
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing a wearable device called Sparrow Link that sends gentle electrical pulses to nerves in the ear to help reduce opioid withdrawal symptoms. About 50 hospitalized adults with opioid use disorder will receive either the active device or a sham version, along with standard care. Researchers will see if patients use the device consistently and if it lowers withdrawal severity, pain, and cravings.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Sparrow Link device (transcutaneous auricular neurostimulation)
- What this could lead to
- If it works, this could offer a non-drug option to help manage opioid withdrawal symptoms in hospitals.
- What could go wrong
- This is a small, early feasibility study (50 people) testing whether patients will use the device at all. The sham control means any benefit may be placebo, and the device may cause discomfort or no improvement.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER (OUD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UPMC Presbyterian
RECRUITINGPittsburgh, Pennsylvania, 15213, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A bold community experiment takes on the opioid crisis
- Can daily text messages help curb opioid cravings and ease chronic pain?
- Ear-Zapping device may ease pain and opioid withdrawal
- New drug shows promise in calming opioid withdrawal
- Jail-Based PTSD therapy could curb overdose deaths after release
- Opioid tapering trial aims to help chronic pain patients cut back